Armata Pharmaceuticals, Inc. (ARMP) vs Outlook Therapeutics, Inc. (OTLK)
- Armata Pharmaceuticals, Inc. ARMP 3.37 +9.06%
- Outlook Therapeutics, Inc. OTLK 0.49 −2.00%
Armata Pharmaceuticals, Inc. and Outlook Therapeutics, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Outlook Therapeutics, Inc. are of similar size ($121.7M and $114.9M). Armata Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −19.3% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs −3,467.0%) and the higher return on invested capital (0.00% vs −89.6%). Across the 16 metrics below, Outlook Therapeutics, Inc. leads on 10 and Armata Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | ARMP | OTLK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 195.62% | 65.16% |
| Operating margin | (734.19%) | 4,781.76% | 0.00% |
| Net margin | (3,467.04%) | 5,253.40% | 0.00% |
| Free cash flow margin | (465.34%) | 4,826.38% | 0.00% |
| Return on equity | 127.83% | 256.92% | (56.36%) |
| Return on assets | (225.11%) | (251.66%) | (48.04%) |
| Return on invested capital | (89.61%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack